Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $120K | $93.0K | $0.00 |
| Revenue growth | — | -22.5% | -100.0% |
| Gross profit | $43.0K | $43.0K | — |
| Gross margin | 35.8% | 46.2% | — |
| Operating income | -$50.8M | -$93.5M | -$96.8M |
| Operating margin | -42363.3% | -100571.0% | — |
| Net income | -$77.1M | -$68.7M | -$141M |
| Net margin | -64242.5% | -73864.5% | — |
| EPS (diluted) | -$45.29 | -$1.62 | -$1.86 |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$42.8M | -$65.5M | -$90.3M |
| Capital expenditures | $359K | $1.76M | $557K |
| Free cash flow | -$43.2M | -$67.3M | -$90.9M |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $33.2M | $67.5M | $81.5M |
| Total assets | $76.2M | $108M | $121M |
| Total liabilities | $114M | $79.7M | $112M |
| Shareholders' equity | -$325M | $28.4M | $9.46M |
| Retained earnings | -$347M | -$415M | -$556M |
| Shares (wtd avg diluted) | 2.08M | 43.5M | 75.8M |
Every figure is extracted from FRACTYL HEALTH, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.